Evaluation of the effect of Carrogated drain in reducing SSI

Not Applicable

Completed

• Conditions: Peritonitis; R10.0; Condition 1: Acute abdomen. Condition 2: Acut peritonitis. Condition 3: Biliary peritonitis. Condition 4: Fecal peritonitis.; Acute abdomen

• Registration Number: IRCT20201022049115N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 158

Inclusion Criteria

Patients diagnosed with acute peritonitis who have undergone acute midline incision surgery
Patients with biliary peritonitis, fecal peritonitis, or patients with obvious pus in the peritoneal cavity
Patients with subcutaneous fat thickness of more than 20 mm

Exclusion Criteria

Patients under 18 years old and over 70 years old
Patients who do not consent to participate in the study
Patients who undergo surgery with incisions other than midline incisions (McBurney incision, cochlear incision, paramedin incision, etc.)
Pregnant patients
Immune deficiency patients (patients with HIV positive serology, patients undergoing immunosuppressive therapy and patients undergoing any chemotherapy in the last 3 months)
Patients for whom any other implant except drain is implanted (including meshplasty, etc.)
Patients who do not visit the clinic at the appointed times for follow up
Patients with a subcutaneous fat thickness of less than 20 mm
Patients with other types of peritonitis (pancreatic peritonitis, etc.)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Surgical site infection. Timepoint: Evaluation of surgical site infection daily during hospitalization and also at the time of patients' visit to the hospital clinic up to 30 days after surgery. Method of measurement: Physical examination.